Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.070
+0.020 (1.90%)
Nov 20, 2024, 4:00 PM EST - Market closed
Achilles Therapeutics Employees
As of December 31, 2023, Achilles Therapeutics had 215 total employees, including 204 full-time and 11 part-time employees. The number of employees decreased by 27 or -11.16% compared to the previous year.
Employees
215
Change (1Y)
-27
Growth (1Y)
-11.16%
Revenue / Employee
n/a
Profits / Employee
-$311,065
Market Cap
43.96M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 215 | -27 | -11.16% |
Dec 31, 2022 | 242 | -10 | -3.97% |
Dec 31, 2021 | 252 | 93 | 58.49% |
Dec 31, 2020 | 159 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Fortress Biotech | 186 |
Accelerate Diagnostics | 134 |
Omega Therapeutics | 94 |
Actinium Pharmaceuticals | 49 |
OncoCyte | 46 |
HCW Biologics | 45 |
Gain Therapeutics | 32 |
Reviva Pharmaceuticals Holdings | 15 |
ACHL News
- 2 days ago - Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market - GlobeNewsWire
- 7 days ago - Achilles Therapeutics Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Achilles Therapeutics Announces Strategic Update - GlobeNewsWire
- 3 months ago - Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewsWire
- 6 months ago - Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines - GlobeNewsWire
- 6 months ago - Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 7 months ago - Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 8 months ago - Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights - GlobeNewsWire